Fig. 7. Photomicrographs showing prostate tissues of the control and treatment groups. (A) is from the control group. (B) is from the 100 mg kg^–1 per day DEHP treatment group and it shows atrophic tubules (black arrow) and mononuclear cell infiltration (asterisks). (C) is from the 200 mg kg^–1 per day DEHP treatment group and it shows congestion (black arrow) and prostatic intraepithelial neoplasia (asterisk). (D) is from the 200 mg kg^–1 per day DEHP treatment group and it shows atrophic tubules (black arrow) and a decrement of secretion (asterisk). (E) is from the 400 mg kg^–1 per day DEHP treatment group and it shows congestion (black arrow) and atrophic tubules (asterisk). (F) is from the 400 mg kg^–1 per day DEHP treatment group and it shows atrophic tubules (asterisks) (all were stained with contrast by H&E, ×200).